Damora Therapeutics, Inc.

NASDAQ:DMRA

Biotechnology

Healthcare
$22.98 +0.34%

+$0.07 today

Market cap
$1.42B
Beta
1.48
P/E (TTM)
-0.1
EPS (TTM)
-$177.15
52W Low $2.45High $38.33

Volume 0.58M

Average 0.33M

DMRA Net Margin

Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.

No reported Net Margin figures are available to summarize.

Net Margin history

Percent of revenue · from the income statement

No Net Margin data reported for this period type.

Net Margin vs competitors

How DMRA compares with its peers on the latest reported figures

DMRA Competitors Peer median
Net Margin for DMRA and competitors
Company Period LTM level YoY 3-year change
RIGLRigel Pharmaceuticals, Inc.LTM Mar 2026121.5% +103.2 pp+173.4 pp
INCYIncyte CorporationLTM Jun 202627.7% +8.7 pp+15.0 pp
GMABGenmab A/SLTM Jun 202619.1% —-11.7 pp
GERNGeron CorporationLTM Mar 2026-35.5% +84.1 pp+23762.2 pp
KROSKeros Therapeutics, Inc.LTM Mar 2026-256.6% -258.6 pp—
QUREuniQure N.V.LTM Mar 2026-1154.4% -77.4 pp-1116.9 pp
DMRADamora Therapeutics, Inc.FY2025— ——
IRONDisc Medicine, Inc.FY2025— ——
COAGHemab Therapeutics Holdings, Inc. Common StockFY2025— ——
Peer median (excluding DMRA) -8.2%+8.7 pp+15.0 pp

Competitors are the stored peer set for DMRA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue441K490K830K181K0
Gross Profit(441K)(490K)(830K)(181K)0
Gross Margin—————
Research & Development38.49M48.21M23.77M6.4M201.19M
Selling, General & Admin13.3M12.51M11.86M10.32M9.69M
Operating Expenses51.79M60.72M35.63M16.72M210.87M
Depreciation & Amortization441K490K830K181K34K
EBITDA(51.31M)(61.13M)(37.52M)(21.22M)(209.76M)
EBITDA Margin—————
Operating Income(52.23M)(61.21M)(36.46M)(16.9M)(210.87M)
Operating Margin—————
Interest Income156K722K1.69M844K1.17M
Interest Expense00000
Other Income / Expenses475K(417K)(1.89M)(4.5M)1.08M
Income Before Tax(51.75M)(61.62M)(38.35M)(21.4M)(209.79M)
Pre-Tax Margin—————
Income Tax Expense00041K50K
Net Income(51.75M)(61.62M)(38.35M)(21.44M)(209.84M)
Net Margin—————
EPS (Basic)(51.22)(60.63)(36.08)(18.53)(158.13)
EPS (Diluted)(51.22)(60.63)(36.08)(18.53)(158.13)
Weighted Avg Shares1.01M1.02M1.06M1.16M1.33M
Weighted Avg Shares (Diluted)1.01M1.02M1.06M1.16M1.33M

Damora Therapeutics, Inc.

NASDAQ:DMRA

Intrinsic Alpha fair value

Locked

Current Price

$22.98

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.